Frank A. Holtkamp
Medicines Evaluation Board(NL)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management, Lipoproteins and Cardiovascular Health, Cardiac electrophysiology and arrhythmias
Most-Cited Works
- → An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function(2011)350 cited
- → Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers(2012)247 cited
- → Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials(2011)123 cited
- → Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints(2017)53 cited
- → Monitoring Kidney Function and Albuminuria in Patients With Diabetes(2011)46 cited
- → Change in Albuminuria and Estimated GFR as End Points for Clinical Trials in Early Stages of CKD: A Perspective From European Regulators(2019)19 cited
- → Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome(2016)17 cited
- → Quality of drug label information on QT interval prolongation(2014)6 cited
- → Safety information on QT-interval prolongation: comparison of European Union and United States drug labeling(2014)5 cited
- → The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors(2015)2 cited